Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Diaceutics (DXRX)

Price 133.50p on 09-10-2024 at 10:00:27
Change 0.00p 0%
Buy 135.00p
Sell 132.00p
Buy / Sell DXRX Shares
Last Trade: Sell 122.00 at 133.10p
Day's Volume: 122
Last Close: 133.50p
Open: 133.50p
ISIN: GB00BJQTGV64
Day's Range 133.50p - 133.50p
52wk Range: 82.50p - 136.00p
Market Capitalisation: £113m
VWAP: 133.10p
Shares in Issue: 84m

Recent Trades History Diaceutics (DXRX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 122 133.10p Ordinary
09:44:02 - 09-Oct-24

Share Price History for Diaceutics

Time period:
to
Date Open High Low Close Volume

Share News for Diaceutics

EXECUTIVE CHANGES: Dar Global chair exits; new CFOs at Kistos, Hansard

2nd Oct 2024 13:35

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced recently and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: McBride swings to profit; Headlam in the red

17th Sep 2024 13:03

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Shield Therapeutics lands Canada win; RUA revenue up

27th Aug 2024 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Diaceutics to unlock new revenue with multi-million pound partnership

19th Aug 2024 11:44

(Alliance News) - Diaceutics PLC on Monday announced the launch of PMx services alongside a new promotional partnership with a US biotech firm. Read More

IN BRIEF: Diaceutics says Non-Executive Chair Deborah Davis resigns

23rd Jul 2024 20:54

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Says that Non-Executive Chair Deborah Davis intends to step down from the board, effective October 1. Peter Keeling, a co-founder and executive director of Diaceutics, will succeed Davis in the role from the date of her departure. Read More

FTSE 100 Latest
Value8,210.85
Change20.24

Login to your account

Forgot Password?

Not Registered